|
|
TTD Drug ID:
DCL000193
Drug
Information |
Name | Pasireotide | Company | Novartis | Indication | Neuroendocrine Tumor; Carcinoid Tumor; Pancreatic Neuroendocrine Tumor [ICD9: 140-199, 157.4, 209, 209.4, 209.5, 209.6, 210-229 ICD10: C00-C75, C25.4, C75, C7A, C7B, D10-D36, D3A, E34.0] | Phase I [1] | Pancreatic Cancer | Phase III [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-2 4-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57( 74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9 -19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)4 5/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2, (H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,4 7+,48-,49+,50+,51?/m0/s1 | InChIKey | VMZMNAABQBOLAK-CIXMYWCRSA-N | Canonical SMILES | C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4= CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN | Isomeric SMILES | C1[C@@H](CN2[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N [C@@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC= CC=C76)C8=CC=CC=C8)OC(=O)NCCN | CAS Number | CAS 396091-73-9 | PubChem Compound ID | CID 71300636. | SuperDrug ATC ID | H01CB05 | H01CB05 | ClinicalTrials.gov | NCT00804336; | NCT00994110; | Target | Somatostatin receptor type 1 |  | Agonist | [1] | Somatostatin receptor type 1 |  | Multitarget | [1] | Somatostatin receptor type 2 |  | Agonist | [1] | Somatostatin receptor type 2 |  | Multitarget | [1] | Somatostatin receptor type 3 |  | Agonist | [1] | Somatostatin receptor type 3 |  | Multitarget | [1] | Somatostatin receptor type 5 |  | Agonist | [1] | Somatostatin receptor type 5 |  | Multitarget | [1] | Ref 1 | Treatment strategies for acromegaly. Expert Opin Emerg Drugs. 2005 Nov;10(4):875-90. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|